MEDPAL AI is trading 10.47% up at Β£4.47, with the move best classified as healthcare-sector driven rather than linked to a fresh company catalyst.
- No new company-specific announcement was identified for August 11, 2026.
- The latest listed RNS remains the August 4 July Trading Update, reporting annualised recurring revenue above Β£8.6 million and record NHS prescription volumes.
- The update does not directly explain the August 10-11 move; evidence linking it to todayβs gain is limited.